AnaptysBio
$29.469876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$29.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.16 (+0.55%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell AnaptysBio and other stocks, options, and ETFs commission-free!
About ANAB
AnaptysBio, Inc. Common Stock, also called AnaptysBio, is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Read More Its products pipeline include ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA. The listed name for ANAB is AnaptysBio, Inc. Common Stock.
CEO
Hamza Suria
Employees
89
Headquarters
San Diego, California
Founded
2005
Market Cap
804.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
501.45K
High Today
$30.39
Low Today
$28.84
Open Price
$29.12
Volume
440.09K
52 Week High
$39.48
52 Week Low
$10.00
Collections
Analyst Ratings
14%
of 7 ratings
Buy
14%
Hold
71%
Sell
14%
ANAB Earnings
-$1.20
-$0.80
-$0.40
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected Nov 5, Pre-Market